Alfentanil anesthetic augmentation lengthens seizure duration in electroconvulsive therapy with older people

Int Psychogeriatr. 2016 Jun;28(6):1051-2. doi: 10.1017/S1041610216000119. Epub 2016 Feb 5.

Abstract

Electroconvulsive therapy (ECT) prescription rates rise with age, making it important that treatments be made as effective and safe as possible (Plakiotis et al., 2012). Older people are vulnerable to post-treatment confusion and to subsequent deficits in attention, new learning, and autobiographical memory (Gardner and O'Connor, 2008). Strategies to minimize cognitive side-effects include unilateral electrode placement and stimulus dose titration whereby electrical charge is individually calibrated to seizure threshold (Sackeim et al., 2000). It remains the case, however, that threshold levels typically rise over the treatment course, leading to an increase both in delivered charge and the risk of adverse sequelae.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alfentanil / administration & dosage*
  • Anesthesia Recovery Period
  • Anesthetics / administration & dosage*
  • Anesthetics, Intravenous / administration & dosage*
  • Dose-Response Relationship, Drug
  • Electroconvulsive Therapy / adverse effects
  • Electroconvulsive Therapy / methods*
  • Female
  • Humans
  • Male
  • Propofol / therapeutic use
  • Seizures / diagnosis
  • Seizures / drug therapy
  • Seizures / etiology
  • Seizures / physiopathology*
  • Seizures / therapy*
  • Time Factors
  • Treatment Outcome

Substances

  • Anesthetics
  • Anesthetics, Intravenous
  • Alfentanil
  • Propofol